Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial: Figure 1
Laakso, Markku, Rosenstock, Julio, Groop, Per-Henrik, Barnett, Anthony H., Gallwitz, Baptist, Hehnke, Uwe, Tamminen, Ilkka, Patel, Sanjay, von Eynatten, Maximilian, Woerle, Hans-JuergenVolume:
38
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc14-1684
Date:
February, 2015
File:
PDF, 825 KB
english, 2015